Results from Recent Pivotal Trials in Prostate Cancer - Cora Sternberg

Cora Sternberg joins Alicia Morgans in a discussion on practice transforming presentations in prostate cancer from the 2019 GU ASCO meeting. Among the presentations  overviewed is the ARAMIS trial in nonmetastatic castration-resistant prostate cancer (mnCRPC) where Cora highlights its similarities to the PROSPER and SPARTAN trials. They discuss progression-free survival in the second update on the SPARTAN trial and in the metastatic hormone-sensitive setting Cora reviews the efficacy of enzalutamide in the ARCHES trial.


Cora Sternberg MD, FACP Clinical Director of the Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, Former Chief of the Department of Medical Oncology at the San Camillo-Forlanini Hospital in Rome, Italy

Alicia Morgans, MD, MPH, Associate Professor of Medicine in the Division of Hematology/Oncology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois.


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.